Viewing Study NCT01571661


Ignite Creation Date: 2025-12-24 @ 12:18 PM
Ignite Modification Date: 2026-01-24 @ 9:45 PM
Study NCT ID: NCT01571661
Status: COMPLETED
Last Update Posted: 2012-04-05
First Post: 2012-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module